We rank companies based on fund manager, research analyst and news sentiment
ATNF stock icon

180 Life Sciences Corp. Common Stock
ATNF

$2.04
5.32%
 

About: 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

Employees: 4

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more funds holding

Funds holding: 18 [Q3] → 18 (+0) [Q4]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

5.82% less ownership

Funds ownership: 12.06% [Q3] → 6.24% (-5.82%) [Q4]

70% less capital invested

Capital invested by funds: $438K [Q3] → $133K (-$304K) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for ATNF.

Financial journalist opinion